Cargando…

Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors

γ‐Glutamylamine synthetases are an important class of enzymes that play a key role in glutamate‐based metabolism. Methionine sulfoximine (MSO) is a well‐established inhibitor for the archetypal glutamine synthetase (GS) but inhibitors for most GS‐like enzymes are unknown. Assuming a conserved cataly...

Descripción completa

Detalles Bibliográficos
Autores principales: Purder, Patrick L., Meyners, Christian, Krysenko, Sergii, Funk, Jonathan, Wohlleben, Wolfgang, Hausch, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826267/
https://www.ncbi.nlm.nih.gov/pubmed/35976722
http://dx.doi.org/10.1002/cbic.202200312
_version_ 1784866810117488640
author Purder, Patrick L.
Meyners, Christian
Krysenko, Sergii
Funk, Jonathan
Wohlleben, Wolfgang
Hausch, Felix
author_facet Purder, Patrick L.
Meyners, Christian
Krysenko, Sergii
Funk, Jonathan
Wohlleben, Wolfgang
Hausch, Felix
author_sort Purder, Patrick L.
collection PubMed
description γ‐Glutamylamine synthetases are an important class of enzymes that play a key role in glutamate‐based metabolism. Methionine sulfoximine (MSO) is a well‐established inhibitor for the archetypal glutamine synthetase (GS) but inhibitors for most GS‐like enzymes are unknown. Assuming a conserved catalytic mechanism for GS and GS‐like enzymes, we explored if subtype‐selective inhibitors can be obtained by merging MSO with the cognate substrates of the respective GS‐like enzymes. Using GlnA4( Sc ) from Streptomyces coelicolor, an enzyme recently shown to produce γ‐glutamylethanolamine, we demonstrate that MSO can be reengineered in a straightforward fashion into potent and selective GlnA4( Sc ) inhibitors. Linkage chemistry as well as linker length between the MSO moiety and the terminal hydroxyl group derived from ethanolamine were in agreement with the postulated phosphorylated catalytic intermediate. The best GlnA4 inhibitor 7 b potently blocked S. coelicolor growth in the presence of ethanolamine as the sole nitrogen source. Our results provide the first GlnA4( Sc )‐specific inhibitors and suggest a general strategy to develop mechanism‐based inhibitors for GS‐like enzymes.
format Online
Article
Text
id pubmed-9826267
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98262672023-01-09 Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors Purder, Patrick L. Meyners, Christian Krysenko, Sergii Funk, Jonathan Wohlleben, Wolfgang Hausch, Felix Chembiochem Research Articles γ‐Glutamylamine synthetases are an important class of enzymes that play a key role in glutamate‐based metabolism. Methionine sulfoximine (MSO) is a well‐established inhibitor for the archetypal glutamine synthetase (GS) but inhibitors for most GS‐like enzymes are unknown. Assuming a conserved catalytic mechanism for GS and GS‐like enzymes, we explored if subtype‐selective inhibitors can be obtained by merging MSO with the cognate substrates of the respective GS‐like enzymes. Using GlnA4( Sc ) from Streptomyces coelicolor, an enzyme recently shown to produce γ‐glutamylethanolamine, we demonstrate that MSO can be reengineered in a straightforward fashion into potent and selective GlnA4( Sc ) inhibitors. Linkage chemistry as well as linker length between the MSO moiety and the terminal hydroxyl group derived from ethanolamine were in agreement with the postulated phosphorylated catalytic intermediate. The best GlnA4 inhibitor 7 b potently blocked S. coelicolor growth in the presence of ethanolamine as the sole nitrogen source. Our results provide the first GlnA4( Sc )‐specific inhibitors and suggest a general strategy to develop mechanism‐based inhibitors for GS‐like enzymes. John Wiley and Sons Inc. 2022-09-06 2022-10-06 /pmc/articles/PMC9826267/ /pubmed/35976722 http://dx.doi.org/10.1002/cbic.202200312 Text en © 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Purder, Patrick L.
Meyners, Christian
Krysenko, Sergii
Funk, Jonathan
Wohlleben, Wolfgang
Hausch, Felix
Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors
title Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors
title_full Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors
title_fullStr Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors
title_full_unstemmed Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors
title_short Mechanism‐Based Design of the First GlnA4‐Specific Inhibitors
title_sort mechanism‐based design of the first glna4‐specific inhibitors
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826267/
https://www.ncbi.nlm.nih.gov/pubmed/35976722
http://dx.doi.org/10.1002/cbic.202200312
work_keys_str_mv AT purderpatrickl mechanismbaseddesignofthefirstglna4specificinhibitors
AT meynerschristian mechanismbaseddesignofthefirstglna4specificinhibitors
AT krysenkosergii mechanismbaseddesignofthefirstglna4specificinhibitors
AT funkjonathan mechanismbaseddesignofthefirstglna4specificinhibitors
AT wohllebenwolfgang mechanismbaseddesignofthefirstglna4specificinhibitors
AT hauschfelix mechanismbaseddesignofthefirstglna4specificinhibitors